Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Cancer. 2011 Jul 12;118(3):797–803. doi: 10.1002/cncr.26338

Table 3.

Relative risk (RR) and 95% confidence intervals (CIs) of renal cell carcinoma according to history of regular use of statin drugs in the Nurses’ Health Study (1994–2008) and the Health Professionals Follow-Up Study (1990–2006)

Variable Never users Ever users Duration of use
< 4 years ≥ 4 years
Women
 Number of cases 118 46 21 25
 Age-adjusted RR 1.0 0.96 (0.67–1.36) 0.90 (0.56–1.44) 1.02 (0.65–1.60)
 Age and hypertension – adjusted RR 1.0 0.85 (0.59–1.21) 0.80 (0.50–1.28) 0.89 (0.56–1.41)
 Multivariate* RR 1.0 0.76 (0.53–1.10) 0.75 (0.47–1.21) 0.77 (0.49–1.23)
Men
 Number of cases 82 31 11 20
 Age-adjusted RR 1.0 1.26 (0.81–1.94) 0.93 (0.49–1.76) 1.60 (0.94–2.70)
 Age and hypertension adjusted RR 1.0 1.07 (0.69–1.66) 0.80 (0.42–1.53) 1.34 (0.79–2.29)
 Multivariate* RR 1.0 1.03 (0.66–1.60) 0.80 (0.42–1.53) 1.25 (0.73–2.14)
*

The models were adjusted for the same covariates as the multivariate model in Table 2.